Homepage | Collect | 中文版
Home Profile Products R&D Hr Culture Contact Us  
   Jiangsu Zenji Pharmaceuticals LTD.is the predecessor of Jiangsu Long Healthcare Limited , situated in industrial park of Hongze county, Jiangsu province, China. Our company is a national high-tech enterprises.It is 180Km far from Nanjing Airport and 50Km far from Huaian Airport.
   It was established on April,2003, approved by FDA of Jiangsu in China. Its investment is RMB 40 million. The main products of the company as a stomach medicine series of cimetidine products, as well as the innovation of customized products, innovative products include Pitavastatin,Ezetimibe,Loxoprofen,Bazedoxifene Acetate,Sofosbuvir,Dapagliflozin......
Philosophy and objectives:
   Based on the raw material medicine industry, to improve the health of human life,the "Quality,Innovation,Activity Reliable", the pursuit of sustainable development, to create a global influential raw materials research and development and production of customized services brand of modern enterprises
The idea of human resource:
   Always put the people 's initiative as the company's development capital, for the staff to provide a broad development space, advocated by the staff with the company grow together, realize self value.
tel:15161706520 mail:office@dg-syjx.com
Online: Click here to give me a message Click here to give me a message
CAS NO.:51481-61-9
It is Histamine H2 receptor antagonist and synthesized in 1974 and launched to market in 1975 by S&K.
CAS No.:71130-06-8
It is Histamine H2 receptor antagonist and developed by Glaxo in 1981
Stomach medicine, famotidine intermediates,veterinary medicine, printing and dyeing
The main products are Pitavastatin,Ezetimibe,Loxoprofen,Bazedoxifene Acetate,Sofosbuvir,Dapagliflozin
© 2003 - 2015 Jiangsu Zenji Pharmaceuticals LTD. All Rights Reserved